Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HACD4 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | FCER2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | IFRD2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | SLC25A40 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | LEF1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | RSPO3 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | TARS2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
mRNA | ASAP1 | FIMM | pan-cancer | AAC | 0.42 | 0.007 |
mRNA | GLTSCR2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
mRNA | ARL3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |